| Application no. and date | 01116338.3 (espacenet) (Federated) (European Patent Register), 19960708 | | Patent/reg. no. and date | DK/EP 1148049, 20041215 | | Publication date | 20011024 | | Priority no. and date | US 1452 P, 19950717 | | EP pub. no. and date |
EP 1148049 20011024 | | Effective date | | | Applicant/owner | Warner-Lambert Company LLC, 201 Tabor Road
Morris Plains,
New Jersey 07950, US | | Applicant ref. no. | 119886 | | Inventor | Briggs, Christopher A., 643 East 12th Street
Holland,
Michigan 49423, US,
Jennings, Rex Allen, 405 Lincoln Avenue
Holland,
Michigan 49423, US,
Wade, Robert A., 3882 62nd Street
Holland,
Michigan 49423, US,
Harasawa, Kikuko,
202 Liberty Palace, Odakyusagamihara,
18-15 Minamidai
6-chome,
Sagamihara-shi,
Kanagawa 228, JP,
Ichikawa, Shigeru, D-403 Cl-Heights,
1356 Yamasaki-cho
Machida-shi,
Tokyo 195, JP,
Minohara, Kazuo, 702 Park Heights Sagamihara,
4-4 Sagamihara
5-chome,
Sagamihara shi,
Kanagawa 229, JP,
Nakagawa, Shinsuke, 303 Seishin-Hills,
14-30 Seishin 7-chome
Sagamihara-shi,
Kanagawa 229, JP | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/40 (2006.01) , C07D 207/34 (2006.01) | | Title | Krystallinsk [R-(R*,R*)]-2-(4-fluorphenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4- [(phenylamino)carbonyl]-1H-pyrrol-1-heptansyre-hemicalciumsalt (ATORVASTATIN) | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
